211 related articles for article (PubMed ID: 36820986)
1. Mfsd2a attenuated hypoxic-ischemic brain damage via protection of the blood-brain barrier in mfat-1 transgenic mice.
Li X; Zhang Y; Chang J; Zhang C; Li L; Dai Y; Yang H; Wang Y
Cell Mol Life Sci; 2023 Feb; 80(3):71. PubMed ID: 36820986
[TBL] [Abstract][Full Text] [Related]
2. Selective sphingosine-1-phosphate receptor 1 modulator attenuates blood-brain barrier disruption following traumatic brain injury by inhibiting vesicular transcytosis.
Zhang Y; Wang L; Pan Q; Yang X; Cao Y; Yan J; Wang Y; Tao Y; Fan R; Sun X; Li L
Fluids Barriers CNS; 2022 Jul; 19(1):57. PubMed ID: 35820896
[TBL] [Abstract][Full Text] [Related]
3. Brain endothelial PTEN/AKT/NEDD4-2/MFSD2A axis regulates blood-brain barrier permeability.
Cui Y; Wang Y; Song X; Ning H; Zhang Y; Teng Y; Wang J; Yang X
Cell Rep; 2021 Jul; 36(1):109327. PubMed ID: 34233198
[TBL] [Abstract][Full Text] [Related]
4. Mfsd2a (Major Facilitator Superfamily Domain Containing 2a) Attenuates Intracerebral Hemorrhage-Induced Blood-Brain Barrier Disruption by Inhibiting Vesicular Transcytosis.
Yang YR; Xiong XY; Liu J; Wu LR; Zhong Q; Zhou K; Meng ZY; Liu L; Wang FX; Gong QW; Liao MF; Duan CM; Li J; Yang MH; Zhang Q; Gong CX; Yang QW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724654
[TBL] [Abstract][Full Text] [Related]
5. Mfsd2a Attenuates Blood-Brain Barrier Disruption After Sub-arachnoid Hemorrhage by Inhibiting Caveolae-Mediated Transcellular Transport in Rats.
Zhao C; Ma J; Wang Z; Li H; Shen H; Li X; Chen G
Transl Stroke Res; 2020 Oct; 11(5):1012-1027. PubMed ID: 31907728
[TBL] [Abstract][Full Text] [Related]
6. Aging decreases docosahexaenoic acid transport across the blood-brain barrier in C57BL/6J mice.
Iwao T; Takata F; Matsumoto J; Aridome H; Yasunaga M; Yokoya M; Kataoka Y; Dohgu S
PLoS One; 2023; 18(2):e0281946. PubMed ID: 36795730
[TBL] [Abstract][Full Text] [Related]
7. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid.
Nguyen LN; Ma D; Shui G; Wong P; Cazenave-Gassiot A; Zhang X; Wenk MR; Goh EL; Silver DL
Nature; 2014 May; 509(7501):503-6. PubMed ID: 24828044
[TBL] [Abstract][Full Text] [Related]
8. The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain.
Chan JP; Wong BH; Chin CF; Galam DLA; Foo JC; Wong LC; Ghosh S; Wenk MR; Cazenave-Gassiot A; Silver DL
PLoS Biol; 2018 Aug; 16(8):e2006443. PubMed ID: 30074985
[TBL] [Abstract][Full Text] [Related]
9. Mfat-1 ameliorates cachexia after hypoxic-ischemic brain damage in mice by protecting the hypothalamus-pituitary-adrenal axis.
Zhang Y; Lu W; Li X; Wang Y; Li L; Dai Y; Yang H; Wang Y
Life Sci; 2023 Nov; 333():122172. PubMed ID: 37832632
[TBL] [Abstract][Full Text] [Related]
10. Mfsd2a: A Physiologically Important Lysolipid Transporter in the Brain and Eye.
Wong BH; Silver DL
Adv Exp Med Biol; 2020; 1276():223-234. PubMed ID: 32705603
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Placental Major Facilitator Superfamily Domain Containing 2a in Pregnant Mice Reduces Fetal Brain Growth and Phospholipid Docosahexaenoic Acid Content.
Powell TL; Barentsen K; Vaughan O; Uhlson C; Zemski Berry K; Erickson K; Faer K; Chassen SS; Jansson T
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068814
[TBL] [Abstract][Full Text] [Related]
12. The Role of Major Facilitator Superfamily Domain-Containing 2a in the Central Nervous System.
He Z; Zhao Y; Sun J
Cell Mol Neurobiol; 2023 Mar; 43(2):639-647. PubMed ID: 35438385
[TBL] [Abstract][Full Text] [Related]
13. Activation of Wnt signaling mitigates blood-brain barrier disruption by inhibiting vesicular transcytosis after traumatic brain injury in mice.
Zhang Y; Xu J; Li P; Luo B; Tang H
Exp Neurol; 2024 Jul; 377():114782. PubMed ID: 38641126
[TBL] [Abstract][Full Text] [Related]
14. Hypertension depresses but exercise training restores both Mfsd2a expression and blood-brain barrier function within PVN capillaries.
Perego SM; Raquel HA; Candido VB; Masson GS; Martins MM; Ceroni A; Michelini LC
Am J Physiol Regul Integr Comp Physiol; 2023 Sep; 325(3):R299-R307. PubMed ID: 37458379
[TBL] [Abstract][Full Text] [Related]
15. Mfsd2a is critical for the formation and function of the blood-brain barrier.
Ben-Zvi A; Lacoste B; Kur E; Andreone BJ; Mayshar Y; Yan H; Gu C
Nature; 2014 May; 509(7501):507-11. PubMed ID: 24828040
[TBL] [Abstract][Full Text] [Related]
16. Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier.
Wang JZ; Xiao N; Zhang YZ; Zhao CX; Guo XH; Lu LM
Pharmacol Res; 2016 Feb; 104():124-31. PubMed ID: 26747400
[TBL] [Abstract][Full Text] [Related]
17. Mfsd2a Is a Transporter for the Essential ω-3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development.
Wong BH; Chan JP; Cazenave-Gassiot A; Poh RW; Foo JC; Galam DL; Ghosh S; Nguyen LN; Barathi VA; Yeo SW; Luu CD; Wenk MR; Silver DL
J Biol Chem; 2016 May; 291(20):10501-14. PubMed ID: 27008858
[TBL] [Abstract][Full Text] [Related]
18. Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases.
Ju X; Miao T; Chen H; Ni J; Han L
Adv Healthc Mater; 2021 May; 10(9):e2001997. PubMed ID: 33738958
[TBL] [Abstract][Full Text] [Related]
19. Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a.
Tiwary S; Morales JE; Kwiatkowski SC; Lang FF; Rao G; McCarty JH
Sci Rep; 2018 May; 8(1):8267. PubMed ID: 29844613
[TBL] [Abstract][Full Text] [Related]
20. Lipid flipping in the omega-3 fatty-acid transporter.
Nguyen C; Lei HT; Lai LTF; Gallenito MJ; Mu X; Matthies D; Gonen T
Nat Commun; 2023 May; 14(1):2571. PubMed ID: 37156797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
